Portfolio
Five fronts. One scientific engineering team.
Each front solves a specific pipeline pain — from the first assay to regulatory validation, biological raw-material authentication and structured CRO partnerships.
In vitro assays · ADMET · Bioanalytics
Pre-Clinical Research
A reference in innovation for pre-clinical assays — everything your study needs in one place.
- Custom in vitro assays
- 2D and 3D cellular models
- Bioanalytics with analytical validation
- ADMET and mechanism of action
Compliance ANVISA · FDA · EMA · ICH
Validation of Diagnostic & Pharmaceutical Products
Development and validation of diagnostic and pharmaceutical products with absolute regulatory compliance.
- ICH Q2(R2) analytical validation
- Molecular method qualification
- Stability studies
- ANVISA / FDA / EMA dossiers
International standard ANSI/ATCC ASN-0002
Cell Line Authentication
Precision and reliability for safe pre-clinical results — 16+ STR markers analyzed in 10 days.
- 16+ STR markers
- Average 10-day turnaround
- ANSI/ATCC ASN-0002 standard
- Repository and traceability
For CROs · Scientific partnership
Base for CROs
Add high-level R&D engineering and ANVISA/FDA infrastructure to your CRO's portfolio — with no fixed costs.
- On-demand assays for your sponsor
- Zero laboratory CAPEX
- Strict NDAs and white-label
- ISO 17025 / GLP standard
Molecular diagnostics · HPV · STIs · Genetics
Women's Health
Molecular biology reference lab — HPV, STIs, gynecological health, fetal sexing and genetics, with nationwide logistics.
- HPV — 28 genotypes, high and low risk
- Multiplex STI panels in a single run
- Bacterial vaginosis, candidiasis, vaginal microbiome
- Fetal sexing from week 8 — 3-day result
- BRCA1/2, thrombophilia, endometriosis, PCOS
- Nationwide logistics and partner portal